Page last updated: 2024-11-07

cellobionolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cellobionolactone is a cyclic derivative of cellobiose, a disaccharide composed of two glucose units linked by a β-(1→4) glycosidic bond. It is a promising candidate for various applications, including:

- **Synthesis:** Cellobionolactone can be synthesized via various methods, including enzymatic hydrolysis of cellulose or chemical oxidation of cellobiose.

- **Effects:** Cellobionolactone has been shown to possess various biological activities, including antibacterial, antifungal, and antioxidant properties.

- **Importance:** It is a renewable and sustainable resource derived from cellulose, a major component of plant biomass.

- **Study:** Research on cellobionolactone focuses on exploring its potential as a precursor for various applications, including bio-based materials, pharmaceuticals, and food additives.

- **Other Applications:** Cellobionolactone has also been investigated as a building block for the synthesis of novel polymers, such as biodegradable plastics and hydrogels.'

cellobionolactone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cellobiono-1,5-lactone : A disaccharide consisting of D-glucono-1,5-lactone having a beta-D-glucosyl residue at the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID99211
CHEBI ID17863
CHEBI ID136504
MeSH IDM0235804

Synonyms (15)

Synonym
beta-d-glucopyranosyl-(1->4)-d-glucono-1,5-lactone
CHEBI:17863
52762-22-8
cellobionolactone
C01093
cellobiose-1,5-lactone
cellobiono-1,5-lactone
CHEBI:136504
(3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-one
nsc 196590
4-o-beta-d-glucopyranosyl-d-gluconic acid delta-lactone
d-gluconic acid, 4-o-beta-d-glucopyranosyl-, delta-lactone
FSICMNGKCHFHGP-ZNLUKOTNSA-N
Q27102668
DTXSID001316284
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
disaccharideA compound in which two monosaccharides are joined by a glycosidic bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]